Opportunity Information: Apply for RFA TS 13 001
Apply for RFA TS 13 001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.161 Health Program for Toxic Substances and Disease Registry.
- This funding opportunity was created on Mar 14, 2013 and posted on Mar 13, 2013.
- Applicants must submit their applications by May 13, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- APPROVED GRANTEE UNDER TS10 001
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation (U01)" is a CDC-funded cooperative agreement designed to support investigator-initiated public health research focused on uranium exposure among Navajo mothers and their infants. The overall purpose is to continue and strengthen a prospective birth cohort study, meaning participants are followed over time, so researchers can more clearly understand how environmental uranium exposure occurs, how it changes during pregnancy and early life, and what that may mean for maternal and infant health. The emphasis is on expanding and advancing scientific knowledge about exposure pathways and levels in this specific population and setting, where legacy uranium mining and related environmental contamination have historically been a concern.
This opportunity was issued by the Centers for Disease Control and Prevention under the funding instrument type "Cooperative Agreement," specifically a U01 mechanism. A cooperative agreement generally indicates substantial involvement by the funding agency compared with a typical research grant, often through technical collaboration, coordination expectations, shared oversight, or structured reporting. The funding activity category is health, and the program is associated with CFDA 93.161, the Health Program for the Agency for Toxic Substances and Disease Registry, reflecting a toxic substances and exposure-focused public health mission.
In terms of funding scale and competition, the announcement anticipated a single award (ExpectedAwards: 1), with an estimated total funding amount of $2,000,000. The award ceiling was listed as $2,000,000, and the floor as $500,000, indicating the CDC expected proposals within that budget range, with up to two million dollars available for the selected project. There was no cost sharing or matching requirement, so applicants were not required to provide non-federal matching funds as a condition of award.
Eligibility was narrow and tied to prior CDC grant status. The listing specifies that eligible applicants are "Others" with clarification in the eligibility section, and it explicitly states "APPROVED GRANTEE UNDER TS10 001." In practical terms, that means only an entity already approved under the referenced earlier award or mechanism (TS10 001) could apply, rather than the opportunity being broadly open to universities, nonprofits, or tribal entities in general. This kind of restricted eligibility often appears when an agency wants to continue or extend an existing, specialized cohort or surveillance effort where continuity, existing infrastructure, and established community relationships are essential.
Key dates show the opportunity was posted March 13, 2013, created March 14, 2013, with an original closing date of June 6, 2013. A revised current closing date is listed as May 13, 2013, suggesting the submission deadline was moved earlier. The archive date was June 12, 2013, meaning the solicitation is no longer active and was formally closed out in the grants listing system after the competition period.
Administrative and applicant support details were routed through the CDC Procurement and Grants Office, Technical Information Management Section (TIMS). The contact information provided includes a phone number (770-488-2700) and email (pgotim@cdc.gov) for help accessing the full announcement. The listing also notes that the "Additional Information" link in the summary view was not active and that applicants would need to open the full announcement through the primary posting interface to access complete requirements, which typically include the project scope, required study components, data management expectations, human subjects protections, collaboration expectations with the Navajo Nation and local partners, and reporting and evaluation deliverables.
Overall, this funding opportunity represents a targeted continuation effort aimed at deepening scientific and public health understanding of environmental uranium exposure during pregnancy and infancy in the Navajo Nation through an ongoing, forward-looking cohort study, supported through a single, relatively large cooperative agreement award with restricted eligibility to an already approved grantee.
Frequently Asked Questions (FAQs)
1. What is the title of this grant opportunity?
The opportunity is titled "Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation (U01)."
2. What is the main purpose of this funding opportunity?
The purpose is to continue and strengthen an existing prospective birth cohort study focused on environmental uranium exposure among Navajo mothers and their infants. By following participants over time, the study aims to better understand how uranium exposure occurs, how exposure levels may change during pregnancy and early life, and what that may mean for maternal and infant health.
3. What kind of research is supported under this announcement?
This is investigator-initiated public health research centered on environmental uranium exposure in the Navajo Nation, with emphasis on expanding and advancing scientific knowledge about exposure pathways and exposure levels in this specific population and setting.
4. What does "prospective birth cohort study" mean in this context?
It means the study follows enrolled participants forward over time (rather than looking back in history). Here, it refers to tracking Navajo mothers and their infants over pregnancy and early life to observe uranium exposure patterns and related health considerations as they unfold.
5. Which federal agency is offering this opportunity?
The opportunity was issued by the Centers for Disease Control and Prevention (CDC).
6. What is the funding instrument type?
The funding instrument is a Cooperative Agreement, specifically using a U01 mechanism.
7. What does a U01 cooperative agreement imply for how the project is run?
A cooperative agreement typically indicates substantial involvement by the funding agency compared with a standard research grant. Based on the listing, this can include technical collaboration, coordination expectations, shared oversight, and structured reporting.
8. What is the funding activity category for this opportunity?
The funding activity category is health.
9. What CFDA number is associated with this program?
The program is associated with CFDA 93.161, the Health Program for the Agency for Toxic Substances and Disease Registry (ATSDR).
10. How many awards were expected?
The announcement anticipated a single award (ExpectedAwards: 1).
11. What was the estimated total funding amount available?
The estimated total funding amount was $2,000,000.
12. What were the award ceiling and award floor?
The award ceiling was $2,000,000 and the award floor was $500,000, indicating CDC expected proposals to fall within that range, with up to two million dollars available for the selected project.
13. Was cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement, meaning applicants were not required to provide non-federal matching funds as a condition of award.
14. Who was eligible to apply?
Eligibility was restricted. The listing specifies "Others" with the explicit condition "APPROVED GRANTEE UNDER TS10 001." In practical terms, only an entity already approved under the referenced earlier award or mechanism (TS10 001) could apply.
15. Is this opportunity open to universities, nonprofits, or tribal entities in general?
Not broadly. Based on the eligibility language provided, it was not generally open to all universities, nonprofits, or tribal entities. It was limited to an approved grantee under TS10 001.
16. Why would eligibility be restricted to an existing approved grantee?
The listing indicates this is a continuation effort where continuity, existing infrastructure, and established community relationships are important. Restricted eligibility commonly appears when an agency intends to extend or continue a specialized cohort or long-term effort rather than start a brand-new project with a new organization.
17. When was the opportunity posted?
The opportunity was posted on March 13, 2013, and created on March 14, 2013.
18. What were the closing dates, and were they changed?
The original closing date was June 6, 2013. A revised current closing date was listed as May 13, 2013, suggesting the submission deadline was moved earlier.
19. Is this grant opportunity still open?
No. The archive date was June 12, 2013, indicating the solicitation is no longer active and was formally closed out after the competition period.
20. What population and setting is the research focused on?
The study focus is on Navajo mothers and their infants in the Navajo Nation, in a context where legacy uranium mining and related environmental contamination have historically been a concern.
21. What is the public health issue being studied?
The central issue is environmental uranium exposure, including how exposure happens (pathways), how exposure levels may vary during pregnancy and early life, and what those exposure patterns may mean for maternal and infant health.
22. What kinds of expectations might be included in the full announcement that are not visible in the summary?
The listing indicates that complete requirements would typically include details such as project scope, required study components, data management expectations, human subjects protections, collaboration expectations with the Navajo Nation and local partners, and reporting and evaluation deliverables.
23. Where were applicant support and administrative questions directed?
Support was routed through the CDC Procurement and Grants Office, Technical Information Management Section (TIMS).
24. What contact information was provided for help accessing the full announcement?
The listing provided a phone number (770-488-2700) and an email address (pgotim@cdc.gov) for assistance.
25. What if the "Additional Information" link in the summary view was not working?
The listing notes the "Additional Information" link was not active in the summary view and that applicants would need to open the full announcement through the primary posting interface to access complete requirements.
26. What makes this opportunity a continuation rather than a brand-new study?
The title and description emphasize "continuing" and "strengthening" an ongoing prospective birth cohort study, and the eligibility restriction to an "APPROVED GRANTEE UNDER TS10 001" reinforces that it was designed to extend an existing effort rather than fund a new entrant.
27. What is the overall takeaway about the scope and intent of this award?
This was a targeted, single-award cooperative agreement intended to deepen scientific and public health understanding of environmental uranium exposure during pregnancy and infancy in the Navajo Nation by supporting an ongoing, forward-looking cohort study with close coordination expectations typical of a U01.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: NOT A REQUEST FOR PROPOSALS, Notice of Intent to Fund KEWE NHP Advisory Commission
Previous opportunity: THIS IS NOT A REQUEST FOR PROPOSALS Notice of Intent to Award Indiana Dunes Learning Center
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA TS 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA TS 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Collaborative Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury Neuropathology and Neuroimaging Correlation (U01) Apply for RFA NS 13 013 Funding Number: RFA NS 13 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Outbreak Prevention Feasibility Project Apply for CDC RFA PS13 1314 Funding Number: CDC RFA PS13 1314 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Acute Kidney Injury in Older Adults (R03) Apply for PA 13 142 Funding Number: PA 13 142 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Acute Kidney Injury in Older Adults (R21) Apply for PA 13 143 Funding Number: PA 13 143 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Establishing a Center for Public Health Training in Complex Humanitarian Emergencies Apply for CDC RFA GH13 1370 Funding Number: CDC RFA GH13 1370 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Egypt Ministry of Health and Population for Global Disease Detection Activities Apply for CDC RFA GH13 1369 Funding Number: CDC RFA GH13 1369 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Apply for CDC RFA DP13 1302 Funding Number: CDC RFA DP13 1302 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers 9th Announcement Apply for CMS 1A1 13 002 Funding Number: CMS 1A1 13 002 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 1306 Funding Number: CDC RFA IP13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| State Offices of Rural Health Grant Program (SORH) Apply for HRSA 13 162 Funding Number: HRSA 13 162 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP13 1305 Funding Number: CDC RFA IP13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Developing Research Capacity to Assess Health Effects Associated with Volcanic Emissions and other Environmental Exposures (R01) Apply for RFA EH 13 002 Funding Number: RFA EH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS13 1305 Funding Number: CDC RFA PS13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| National Center for Environmental Health/Agency for Toxic Substances and Disease Registry Public Health Conference Support Program Apply for CDC RFA EH13 1306 Funding Number: CDC RFA EH13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 13 144 Funding Number: PAR 13 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Animal Models and Related Biological Materials for Research (R21) Apply for PA 13 145 Funding Number: PA 13 145 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Promoting, Strengthening and Enhancing Disease Prevention by Collaboration with Targeted Stakeholders Apply for CDC RFA IP13 1303 Funding Number: CDC RFA IP13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $220,000 |
| USAID/Vietnam Request for Information (RFI) on Healthy Markets Activity Apply for SOL 486 13 00022 Funding Number: SOL 486 13 00022 Agency: Thailand USAID Bangkok Category: Health Funding Amount: $15,000,000 |
| Cooperative Centers on Human Immunology (U19) Apply for RFA AI 13 016 Funding Number: RFA AI 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Limited Competition Dominantly Inherited Alzheimer Network (U19) Apply for PAR 13 147 Funding Number: PAR 13 147 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA TS 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.